Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally

Details for Australian Patent Application No. 2003287488 (hide)

International Classifications

Event Publications

1 April 2004 Complete Application Filed

Priority application(s): 60/425,326 12.11.02 US

8 July 2004 Application Open to Public Inspection

Published as AU-B-2003287488

5 April 2007 Application Accepted

Published as AU-B-2003287488

17 May 2007 Corrigenda

Applications Accepted - Name Index Under the name Teva Pharmaceutical Industries Ltd., Application NO. 2003287488, under INID (72), correct Corrigenda the co-inventor name to read Flashner-Barak, Moshe

2 August 2007 Standard Patent Sealed

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.